Onderneming Longview Acquisition Corp. Nyse
Aandelen
US1241551027
Geavanceerde medische apparatuur & technologie
Vakgebied
Aantal werknemers: 225
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Devices and Accessories
60,8
%
| 50 | 68,5 % | 40 | 60,8 % | -20,35% |
Software and Other Services
39,2
%
| 23 | 31,5 % | 26 | 39,2 % | +11,83% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
79,1
%
| 51 | 69,6 % | 52 | 79,1 % | +2,04% |
International
20,9
%
| 22 | 30,4 % | 14 | 20,9 % | -38,24% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph DeVivo
CEO | Chief Executive Officer | 57 | 24-04-23 |
Founder | 60 | 25-01-11 | |
Heather Getz
DFI | Director of Finance/CFO | 49 | 02-05-22 |
John Martin
CTO | Chief Tech/Sci/R&D Officer | 65 | 01-05-17 |
Andrei Stoica
CTO | Chief Tech/Sci/R&D Officer | 51 | 19-07-21 |
David H. Ramsey
CTO | Chief Tech/Sci/R&D Officer | 54 | 19-07-21 |
Troy Quander
LAW | General Counsel | 53 | 13-09-21 |
Darius Shahida
PRN | Corporate Officer/Principal | 32 | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 60 | 25-01-11 | |
S. Phanstiel
BRD | Director/Board Member | 65 | 12-02-21 |
Lawrence Robbins
BRD | Director/Board Member | 54 | 12-02-21 |
Elazer Edelman
BRD | Director/Board Member | 67 | 10-03-21 |
Joseph DeVivo
CEO | Chief Executive Officer | 57 | 24-04-23 |
Dawn Carfora
BRD | Director/Board Member | 52 | 12-02-21 |
Erica Schwartz
BRD | Director/Board Member | 52 | 08-09-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 26 426 937 | 0 | 0 | 72,98 % |
Aandeel B | 1 | 184 208 929 | 153 714 106 ( 83,45 %) | 0 |
Bedrijfsgegevens
![Adres Longview Acquisition Corp.](https://cdn.zonebourse.com/static/address/109645841.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,16% | 212 mld. | |
+9,62% | 188 mld. | |
+31,18% | 157 mld. | |
+33,37% | 114 mld. | |
+3,46% | 64,01 mld. | |
+1,51% | 48,83 mld. | |
-4,27% | 39,3 mld. | |
+0,88% | 35,97 mld. | |
+8,44% | 27 mld. |